The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

Dr. Peter Marks, the agency's former vaccine chief, refused to grant Health Secretary Robert F. Kennedy Jr.'s team unrestricted access to a vaccine safety database, fearing that the information might ...

Tracy Beth Høeg, MD, PhD, who was named a special assistant to new FDA Commissioner Marty Makary, MD, MPH, previously opposed some health policies during the COVID-19 pandemic and has questioned ...

Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving Long COVID symptoms, according to a new study published in The Lancet Infectious Diseases on April 3. “This is ...

A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...